Commerzbank Aktiengesellschaft FI lessened its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 8.0% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 574,956 shares of the company’s stock after selling 50,243 shares during the period. Procter & Gamble makes up approximately 1.8% of Commerzbank Aktiengesellschaft FI’s holdings, making the stock its 18th largest holding. Commerzbank Aktiengesellschaft FI’s holdings in Procter & Gamble were worth $88,342,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of PG. Norges Bank purchased a new stake in Procter & Gamble in the 2nd quarter worth about $5,099,644,000. Laurel Wealth Advisors LLC increased its stake in Procter & Gamble by 15,971.7% in the second quarter. Laurel Wealth Advisors LLC now owns 7,012,744 shares of the company’s stock worth $1,117,270,000 after purchasing an additional 6,969,110 shares during the period. Vanguard Group Inc. boosted its stake in shares of Procter & Gamble by 1.4% during the second quarter. Vanguard Group Inc. now owns 233,211,283 shares of the company’s stock valued at $37,155,222,000 after purchasing an additional 3,189,111 shares during the period. Invesco Ltd. grew its holdings in shares of Procter & Gamble by 21.4% in the second quarter. Invesco Ltd. now owns 16,374,499 shares of the company’s stock worth $2,608,785,000 after purchasing an additional 2,880,895 shares during the last quarter. Finally, Lazard Asset Management LLC increased its stake in Procter & Gamble by 66.3% in the 2nd quarter. Lazard Asset Management LLC now owns 5,504,749 shares of the company’s stock worth $877,014,000 after buying an additional 2,195,560 shares during the period. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Price Performance
PG opened at $150.19 on Friday. The firm has a market capitalization of $350.95 billion, a PE ratio of 22.25, a price-to-earnings-growth ratio of 5.07 and a beta of 0.39. The business’s 50-day moving average is $144.72 and its two-hundred day moving average is $150.54. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $179.99. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.72 and a quick ratio of 0.51.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 17th. Investors of record on Friday, January 23rd will be given a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend is Friday, January 23rd. Procter & Gamble’s dividend payout ratio is currently 62.67%.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 725 shares of the stock in a transaction dated Thursday, October 30th. The stock was sold at an average price of $149.57, for a total value of $108,438.25. Following the completion of the sale, the chief accounting officer directly owned 979 shares in the company, valued at approximately $146,429.03. This trade represents a 42.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.20% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the stock. Piper Sandler started coverage on shares of Procter & Gamble in a research report on Wednesday, January 7th. They set a “neutral” rating and a $150.00 target price on the stock. Wells Fargo & Company lifted their target price on Procter & Gamble from $158.00 to $165.00 and gave the company an “overweight” rating in a research report on Friday. Raymond James Financial dropped their price target on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research report on Monday, October 20th. Barclays set a $155.00 price target on Procter & Gamble in a research note on Friday, January 16th. Finally, UBS Group upped their price objective on shares of Procter & Gamble from $161.00 to $170.00 and gave the stock a “buy” rating in a research note on Friday. Fourteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $166.70.
Check Out Our Latest Report on Procter & Gamble
Key Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Q2 EPS beat and guidance maintained — P&G reported adjusted EPS of $1.88, topping estimates and reiterating FY2026 EPS guidance, which supports the company’s cash-return profile and dividend reliability. Procter & Gamble Q2 Earnings Beat Estimates, Organic Sales Flat Y/Y
- Positive Sentiment: JPMorgan upgrade lifts sentiment — JPMorgan moved PG from Neutral to Overweight and raised its $165 price target, giving the stock renewed upward momentum from the buy-side. JPMorgan Upgrade
- Positive Sentiment: Unusually large call buying suggests short-term bullish positioning — heavy call-option volume (241k contracts) points to investor speculation on upside around the earnings/news flow (could amplify near-term moves).
- Neutral Sentiment: Innovation initiatives (premium diapers in China) are longer-term growth plays — P&G is pushing Pampers Prestige (silk fibers) to capture premium demand in China; useful for future mix improvement but not an immediate revenue cure. Procter & Gamble is selling diapers made with silk fibers in China as it leans into luxury
- Neutral Sentiment: Management emphasizing data & technology-led reinvention — new CEO/President highlighted investments to improve targeting and margins; positive strategically but execution will take quarters. Procter & Gamble Says Data and Technology Will Support Company’s Reinvention
- Negative Sentiment: Revenue came up short and organic sales were flat — top-line missed consensus as volumes declined in key categories (razors, diapers) and pricing/mix only partly offset weakness, which is why some investors sold into the print. Procter & Gamble misses revenue estimates due to slower US growth
- Negative Sentiment: Tariff/geopolitical and consumer headwinds flagged — management warned of a challenging external environment (tariffs, geopolitical risk) that could pressure volumes and margins, creating near-term uncertainty. Procter & Gamble falls after warning of challenging consumer and geopolitical environment
- Negative Sentiment: Investor reaction remains mixed — analysts raised some forecasts, but coverage notes the quarter was “mixed” (EPS beat, revenue miss, flat organic sales), so expect muted trading and volatility as the market digests forward commentary. How Investors Are Reacting To Procter & Gamble (PG) Steady Earnings, Softer Guidance And Flat Organic Sales
Procter & Gamble Company Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Stories
- Five stocks we like better than Procter & Gamble
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- Your Signature Is Missing – Act Before It’s Too Late
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
